Optiver Holding’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-983,717
Closed -$46.6M 2612
2025
Q4
$50.1M Buy
983,717
+504,729
+105% +$25.8M 0.02% 172
2025
Q3
$26.6M Buy
478,988
+102,186
+27% +$5.98M 0.01% 198
2025
Q2
$26M Buy
376,802
+280,727
+292% +$19.1M 0.01% 131
2025
Q1
$6.67M Sell
96,075
-296,994
-76% -$24.5M ﹤0.01% 195
2024
Q4
$33.8M Buy
393,069
+382,119
+3,490% +$41.3M 0.02% 116
2024
Q3
$1.3M Buy
+10,950
New +$1.46M ﹤0.01% 371
2024
Q2
Sell
-198,440
Closed -$26.3M 966
2024
Q1
$25.5M Buy
198,440
+75,655
+62% +$9.01M 0.01% 201
2023
Q4
$12.7M Buy
+122,785
New +$12.1M 0.01% 262
2023
Q2
Sell
-14,690
Closed -$1.2M 552
2023
Q1
$1.17M Buy
+14,690
New +$1.04M ﹤0.01% 366
2022
Q4
Sell
-210,486
Closed -$12.3M 479
2022
Q3
$10.5M Buy
210,486
+48,714
+30% +$2.61M 0.01% 181
2022
Q2
$9.01M Buy
161,772
+25,242
+18% +$1.4M 0.01% 167
2022
Q1
$7.58M Buy
136,530
+11,038
+9% +$566K 0.01% 149
2021
Q4
$6.03M Buy
125,492
+870
+0.7% +$47.1K 0.01% 185
2021
Q3
$5.98M Buy
+124,622
New +$6.02M 0.01% 159

Other funds holding NVO

Optiver Holding's NVO Position: Q1 2026 in Review

Optiver Holding sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 983,717 shares — an estimated $46.6M sold.

Optiver Holding first reported a position in NVO in Q3 2021 and held it in 14 quarters. The position peaked at $50.1M in Q4 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Optiver Holding reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Optiver Holding sold 983,717 Novo Nordisk shares in Q1 2026, an estimated $46.6M.
  • Optiver Holding first reported a position in Novo Nordisk in Q3 2021 and held it in 14 quarters.
  • Optiver Holding's Novo Nordisk position peaked at $50.1M in Q4 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.